| 000 | 01083 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513161018.0 | ||
| 264 | 0 | _c19990219 | |
| 008 | 199902s 0 0 eng d | ||
| 022 | _a0007-1048 | ||
| 024 | 7 |
_a10.1046/j.1365-2141.1998.1161c.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarton, L M | |
| 245 | 0 | 0 |
_aManagement of resistance to lymphoblastoid interferon alpha in chronic myeloid leukaemia. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cDec 1998 |
||
| 300 |
_a1208-9 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xtherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 700 | 1 | _aGreen, A R | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 103 _gno. 4 _gp. 1208-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2141.1998.1161c.x _zAvailable from publisher's website |
| 999 |
_c9848126 _d9848126 |
||